ABNOM
☆ Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
References
Iyo Q-switched Nd:YAG laser inozivikanwa kurapa nevus yeOta uye mamiriro akafanana. Takaita chidzidzo kuti tione kuti high-fluence 1064 nm Q-switched Nd:YAG laser yakashanda sei panzvimbo dzeMongolia munzvimbo dzisina kujairika, pasina kuita kuti ganda ripenye. Takadzidza varwere makumi matanhatu nemumwe vane mavara aya, tichiongorora huwandu hwe70 maronda. Hafu yezvironda zvakarapwa nelaser, nepo vamwe vakasiiwa vasina kurapwa kuti vaenzaniswe. Takaongorora zvabuda tichishandisa chikero nemudziyo unonzi Mexameter® kuyera mazinga e melanin. Varwere vakateverwa kweavhareji yemwedzi ye14 muboka rekurapa uye mwedzi ye18 muboka rekucherechedza. Pakupera kwechidzidzo, takawana misiyano yakakura muchiyero chezviyero uye mazinga emelanin pakati pemapoka akarapwa uye asina kurapwa, neboka rinorapwa nelaser rinoratidza mhedzisiro iri nani. Iyo high-fluence Q-switched Nd:YAG laser, isina kukonzera kupenya kweganda, yakaratidza kushanda uye yakachengeteka pakurapa aya asina kujairika eMongolia mavara.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
Isu takadzidza kushanda uye kuchengetedzeka kwekushandisa chaiyo laser kurapwa kwe ABNOM , uye takatarisa kuti ndezvipi zvinhu zvinogona kukanganisa mashandire azvinoita. Takatarisa varwere zana negumi vaive ne ABNOM uye vakawana pakati pemaviri kusvika mapfumbamwe ekurapwa kwelaser. Takaona kuti kurapwa kwakashanda zviri nani nguva yakareba yakaitwa, asi kwete muvarwere vakwegura. Yakashandawo zviri nani kune varwere vane ganda rakareruka (rudzi III) uye nzvimbo diki dzakakanganisika (pasi pe10 cm2) . Kuva nemelasma pamwe ne ABNOM kwakaita kuti kurapwa kusashande. Ruvara kana nhamba yenzvimbo dzakakanganisika hazvina kuita mutsauko. Vanosvika 10% yevarwere vakawana mavara matema mushure mekurapwa. Kutanga kurapwa kwakawanda kwakapa zvibereko zvakanaka. Varwere vakura vane ganda rakasvibira uye makwapa akasvibira vanowanzova nemavara matema mushure mekurapwa. Kune varwere vane ABNOM uye melasma, zviri nani kushandisa yakaderera-simba laser kudzivirira kuita kuti melasma iwedzere.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
○ Kurapwa
Whitening agents hazviwanzo batsira. Kusiyana nemelasma, ABNOM inogona kuvandudzwa nelaser kurapwa uye kusiiwa kuti ibviswe pasina kudzoka. Laser kurapwa inogona kuitwa 10 kusvika 20 nguva kurapa ABNOM.
#QS1064 laser